Anti-CD19-CAR-transduced-T-cellsProlonged haematologic toxicity and cytokine release syndrome: 17 case reports

被引:0
|
作者
机构
关键词
D O I
10.1007/s40278-023-38668-x
中图分类号
学科分类号
摘要
引用
收藏
页码:55 / 55
相关论文
共 50 条
  • [42] Duvelisib for Cytokine Release Syndrome Prophylaxis during CD19-Targeted CAR T Cell Therapy
    Slade, Michael
    Rettig, Michael P.
    Crees, Zachary David
    Mehta-Shah, Neha
    Fehniger, Todd A.
    Cashen, Amanda F.
    Pusic, Iskra
    Uy, Geoffrey L.
    Westervelt, Peter
    DiPersio, John
    Ghobadi, Armin
    BLOOD, 2023, 142
  • [44] Biomarkers for Predicting Cytokine Release Syndrome following CD19-Targeted CAR T Cell Therapy
    Tedesco, Victor E.
    Mohan, Chandra
    JOURNAL OF IMMUNOLOGY, 2021, 206 (07): : 1561 - 1568
  • [47] Assessment and management of cytokine release syndrome and neurotoxicity following CD19 CAR-T cell therapy
    Chou, Cassie K.
    Turtle, Cameron J.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2020, 20 (06) : 653 - 664
  • [48] Melatonin as an immunomodulator in CD19-targeting CAR-T cell therapy: managing cytokine release syndrome
    Zheng, Na
    Long, Yihao
    Bai, Zixuan
    Li, Jianing
    Wang, Hongyu
    Song, Dan-Dan
    Liu, Hong-Lin
    Shi, Jian-Hong
    Zhao, Shuli
    JOURNAL OF TRANSLATIONAL MEDICINE, 2024, 22 (01)
  • [49] Melatonin as an immunomodulator in CD19-targeting CAR-T cell therapy: managing cytokine release syndrome
    Na Zheng
    Yihao Long
    Zixuan Bai
    Jianing Li
    Hongyu Wang
    Dan-Dan Song
    Hong-Lin Liu
    Jian-Hong Shi
    Shuli Zhao
    Journal of Translational Medicine, 22
  • [50] Insights into cytokine release syndrome and neurotoxicity after CD19-specific CAR-T cell therapy
    Gauthier, Jordan
    Turtle, Cameron J.
    CURRENT RESEARCH IN TRANSLATIONAL MEDICINE, 2018, 66 (02) : 50 - 52